Vaccine Efficacy and Effectiveness

Vaccine efficacy is the protection a vaccine provides under the controlled conditions of a randomized trial, while vaccine effectiveness is the protection observed when the vaccine is used in real-world populations. Both express the proportional reduction in disease among vaccinated compared with unvaccinated people, and together they connect a vaccine's immunogenicity to the clinical and public-health benefit it delivers.

Definition

Vaccine efficacy is the percentage reduction in disease incidence in a vaccinated group relative to an unvaccinated group under controlled (trial) conditions; vaccine effectiveness is the analogous reduction estimated from observational studies of vaccines used in routine practice.

Scope

The topic covers the definitions of efficacy and effectiveness, the study designs used to estimate each, the relationship between immunogenicity correlates and protection, and why trial efficacy and field effectiveness can differ. It is a methodological and conceptual reference for appraising vaccine evidence, not guidance on vaccine choice or administration.

Core questions

• How are vaccine efficacy and effectiveness defined and estimated?
• Why can effectiveness in the field differ from efficacy in a trial?
• How do immunogenicity correlates of protection relate to measured efficacy?

Key concepts

• Vaccine efficacy (trial-based)
• Vaccine effectiveness (field-based)
• Relative risk reduction
• Correlates of protection
• Observational study designs (cohort, case-control, test-negative)
• Direct versus indirect (herd) effects

Mechanisms

Efficacy is estimated in randomized controlled trials as one minus the ratio of disease incidence in vaccinated to unvaccinated groups, isolating the vaccine's effect by randomization. Effectiveness is estimated after licensure using observational designs — cohort, case-control, and test-negative studies — which must contend with confounding and biases that trials avoid. Plotkin's work links these clinical measures to immunogenicity by establishing correlates of protection: when a measurable immune marker reliably predicts protection, immunogenicity data can bridge to expected efficacy. Differences between efficacy and effectiveness arise from real-world factors such as adherence, storage, population health, circulating strains, and waning immunity; Halloran and colleagues set out the formal designs and parameters for measuring these effects.

Clinical relevance

Distinguishing efficacy from effectiveness helps readers interpret why a vaccine that performed well in trials may show different protection in practice, and how correlates of protection let new vaccines be evaluated. This entry explains how protection is defined and measured at the level of study design and evidence; it is not a basis for individual vaccination decisions, which follow current schedules and guidelines.

Epidemiology

Effectiveness studies also capture population-level phenomena that trials may not, including indirect (herd) protection of unvaccinated people when coverage is high. Estimates of effectiveness inform immunization policy, booster timing, and responses to waning immunity or strain change, and they are routinely updated as real-world data accumulate.

History

Field evaluation of vaccines grew from early observational studies of smallpox and other vaccines into a formal discipline as randomized trials and standardized observational designs were developed in the twentieth century. The articulation of correlates of protection and the codification of vaccine study design in the late twentieth and early twenty-first centuries gave efficacy and effectiveness a rigorous methodological basis.

Debates

How should effectiveness be estimated when trials are not feasible?

Observational designs such as case-control and test-negative studies estimate effectiveness after licensure but are vulnerable to confounding and selection bias; the choice and interpretation of design is a central methodological judgement in vaccine evaluation.

Key figures

• Stanley Plotkin
• M. Elizabeth Halloran
• Ira Longini

Seminal works

• plotkin-2008
• plotkin-2010
• halloran-2010

Frequently asked questions

What is the difference between vaccine efficacy and effectiveness?

Efficacy is the protection measured in a controlled randomized trial, while effectiveness is the protection observed when the vaccine is used in everyday practice. Effectiveness is often somewhat lower because real-world conditions — adherence, storage, population health, circulating strains — differ from the trial setting.

Why can a correlate of protection be used instead of a new efficacy trial?

When an immune marker such as an antibody titre reliably predicts protection, demonstrating that a new or modified vaccine reaches that marker can stand in for a full efficacy trial. This bridging relies on the correlate having been validated against clinical protection.